no scripts enabled
Medikabazaar
Cart
Vecuprove 4mg 10ml Injection

Your Advantages

Vecuprove 4mg 10ml Injection

₹83

Exclusive of 5% GST

Pack Size

Variant unavailable, Please select another variant

Brand: Johnlee

Country of Origin: India

Vecuprove 4mg 10ml Injection contains Vecuronium Bromide 4mg, a non-depolarizing neuromuscular blocking agent used to relax skeletal muscles during surgical procedures and to facilitate endotracheal intubation.

 

Benefits

Vecuronium Bromide works by competitively blocking acetylcholine receptors at the motor end-plate, preventing muscle contraction. This action provides effective muscle relaxation without the initial contractions seen with depolarizing agents. It has a rapid onset and a predictable duration of action, making it suitable for various medical procedures.

 

Uses and Indications

  • Skeletal muscle relaxation during surgical procedures.
  • Facilitation of endotracheal intubation.
  • To provide skeletal muscle relaxation during mechanical ventilation.
  • Facilitation of emergency airway management in patients in intensive care.

The Vecuprove 4mg 10ml Injection contains:

  • Vecuronium Bromide IP 4mg (active ingredient).
  • Excipients (typically include citric acid anhydrous, sodium phosphate dibasic anhydrous, mannitol, and pH adjusters).
Active Ingredient(s)Vecuronium Bromide 4mg
Therapeutic ClassMuscle Relaxants
Route of AdministrationIntravenous (IV) Injection
Storage ConditionsStore dry powder at 20° to 25°C (68° to 77°F), protected from light.
Regulatory ApprovalCDSCO Approved
Licensed IndicationsSkeletal muscle relaxation during surgery, facilitation of endotracheal intubation, and mechanical ventilation.
SchedulePrescription Only

Dosage and Administration

Vecuprove 4mg 10ml Injection is for intravenous use only. This medicine must be administered by or under the supervision of experienced clinicians familiar with neuromuscular blocking agents. The exact dosage is highly individualized and will be determined by the prescribing doctor based on the patient's condition, the type of procedure, and other concurrent medications. Monitoring of muscle twitch response to peripheral nerve stimulation is advised to guide administration and ensure optimal muscle relaxation. Reconstituted Vecuronium Bromide solution has an acidic pH and should not be mixed with alkaline solutions (e.g., barbiturate solutions such as thiopental) in the same syringe or administered simultaneously through the same intravenous line.

 

Storage and Disposal

  • Store the dry powder at 20° to 25°C (68° to 77°F).
  • Protect from light and retain in carton until time of use.
  • When reconstituted with compatible IV solutions not containing an antimicrobial preservative (e.g., sterile water for injection), refrigerate and use within 24 hours. Discard any unused portion.
  • If reconstituted with bacteriostatic water for injection, use within 5 days.
  • Dispose of contents/container in accordance with local/regional/national/international regulations.

Precautions and Safety

  • Vecuprove 4mg 10ml Injection should only be administered by adequately trained individuals familiar with its actions and potential complications.
  • Facilities for intubation, artificial respiration, oxygen therapy, and reversal agents must be immediately available.
  • Patients should be closely monitored for lung function, and ventilatory support is mandatory until adequate respiration is restored.
  • Severe anaphylactic reactions, which can be life-threatening, have been reported with neuromuscular blocking agents, including vecuronium bromide.
  • Caution is advised in patients with liver disease, lung or breathing disease (e.g., asthma, COPD), or myasthenia gravis.
  • Vecuronium bromide is contraindicated in patients with known hypersensitivity to it.
  • Inform your doctor about all other medicines you are using, as certain antibiotics, seizure medications, lithium, local anesthetics, magnesium supplements, procainamide, and quinidine can interact with vecuronium.
  • Use in pregnant women is only recommended if clinically needed and benefits outweigh risks; discuss with a doctor.
  • Breastfeeding should be stopped for a certain period after administration as per doctor's direction.
  • Patients should not drive or operate heavy machinery for at least 24 hours after receiving the injection.

 

Side Effects and Risks

  • The most frequent adverse reaction is an extension of the drug's pharmacological action beyond the needed time, ranging from skeletal muscle weakness to profound and prolonged skeletal muscle paralysis, potentially leading to respiratory insufficiency or apnea.
  • Other reported side effects include skin rash, increased saliva production, injection site reactions (pain, swelling, redness), and high blood pressure.
  • Allergic reactions such as itching, hives, and swelling of the face, lips, tongue, or throat can occur.
  • Rarely, high fever, excessive sweating, fast or shallow breathing, fast or irregular heartbeat, and muscle stiffness or spasms may be observed.
  • Inadequate reversal of neuromuscular blockade is possible.

 

Disclaimer

Use this medicine only under the prescription and guidance of a qualified doctor or pharmacist.

twitterlinkedinfacebookinstagramyoutube
@Copyright Boston Ivy Healthcare Solutions Private Limited